See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · InformexUSA 2012 · New Orleans, Louisiana · February 14-17, 2012 · Booth 2514

Fulvestrant

Cayman Chemical Item Number 10011269

ICI 182,780; Faslodex® (CAS 129453-61-8)

Fulvestrant (CAS 129453-61-8)

See more

Description

Fulvestrant is a potent estrogen receptor (ER) antagonist that works by down-regulating and degrading the estrogen receptor, ERα.1 The prescription drug, Faslodex®, is efficacious in the treatment of estrogen-sensitive breast cancer, in part because it largely lacks agonist activity in relevant tissues.2 However, fulvestrant was found to fully activate ER on rat hippocampal neurons,3 suggesting it might afford protective neurological benefits with aging.

1 Kansra, S., Yamagata, S., Sneade, L., et al. Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release. Mol Cell Endocrinol 239 27-36 (2005).

2 Addo, S., Yates, R.A., and Laight, A. A phase I trial to assess the pharmacology of the new oestrogen receptor antagonist fulvestrant on the endometrium in healthy postmenopausal volunteers. Br J Cancer 87 1354-1359 (2002).

3 Zhao, L., O'Neill, K., and Brinton, R.D. Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: Implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile. J Pharmacol Exp Ther 319(3) 1124-1132 (2006).

Synonyms
  • ICI 182,780
  • Faslodex®
Formal Name 7α-​[9-​[(4,​4,​5,​5,​5-​pentafluoropentyl)sulfinyl]nonyl]-​estra-​1,​3,​5(10)-​triene-​3,​17β-​diol
CAS Number 129453-61-8
Molecular Formula C32H47F5O3S
Formula Weight 606.8
Formulation A crystalline solid
Purity ≥98%
Stability 2 years
Storage -20°C
Shipping Room temperature in continental US; may vary elsewhere
SMILES
Copy SMILES to clipboard
O=S(CCCCCCCCCC1Cc2cc(O)​ccc2C2CC[C@]​3(C)​[C@@H]​(O)​CCC3C12)​CCCC(F)​(F)​C(F)​(F)​F

Background Reading

Kansra, S., Yamagata, S., Sneade, L., et al. Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release. Mol Cell Endocrinol 239 27-36 (2005).

Addo, S., Yates, R.A., and Laight, A. A phase I trial to assess the pharmacology of the new oestrogen receptor antagonist fulvestrant on the endometrium in healthy postmenopausal volunteers. Br J Cancer 87 1354-1359 (2002).

Zhao, L., O'Neill, K., and Brinton, R.D. Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: Implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile. J Pharmacol Exp Ther 319(3) 1124-1132 (2006).
Size Price Quantity Subtotal
1 mg $15.00 $0.00
5 mg $68.00 $0.00
10 mg $120.00 $0.00
50 mg $525.00 $0.00
Bulk Contact
Cart Total $0.00

This product is available in custom sizes and/or larger quantities.

Please contact our Sales Department for a quote or to purchase.

Pricing updated 2012-02-12. Prices are subject to change without notice.

To ask for assistance with one of our products please contact a Technical Support Scientist.

Warning This product is not for human or veterinary use.

Related Products

G-1
Propylpyrazole Triol

Downloads

Batch-specific Information

Login to access batch-specific information

Cayman Chemical is a manufacturer, supplier and vendor of biochemical reagents, assay kits, antibodies, and proteins.

Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?